SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001209191-09-018324
Filing Date
2009-03-25
Accepted
2009-03-25 17:24:58
Documents
1
Period of Report
2009-03-23
Filing Date Changed
2009-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5707
  Complete submission text file 0001209191-09-018324.txt   7402
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Issuer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 501 FIFTH STREET BRISTOL TN 37620
Business Address
Squicciarino Joseph (Reporting) CIK: 0001332129 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15875 | Film No.: 09704753